337 related articles for article (PubMed ID: 28674842)
1. Clinical Relevance and Predictive Value of Damage Biomarkers of Drug-Induced Kidney Injury.
Kane-Gill SL; Smithburger PL; Kashani K; Kellum JA; Frazee E
Drug Saf; 2017 Nov; 40(11):1049-1074. PubMed ID: 28674842
[TBL] [Abstract][Full Text] [Related]
2. Clinical prospects of biomarkers for the early detection and/or prediction of organ injury associated with pharmacotherapy.
Tajima S; Yamamoto N; Masuda S
Biochem Pharmacol; 2019 Dec; 170():113664. PubMed ID: 31606409
[TBL] [Abstract][Full Text] [Related]
3. Kinetic eGFR and Novel AKI Biomarkers to Predict Renal Recovery.
Dewitte A; Joannès-Boyau O; Sidobre C; Fleureau C; Bats ML; Derache P; Leuillet S; Ripoche J; Combe C; Ouattara A
Clin J Am Soc Nephrol; 2015 Nov; 10(11):1900-10. PubMed ID: 26342047
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit.
Doi K; Negishi K; Ishizu T; Katagiri D; Fujita T; Matsubara T; Yahagi N; Sugaya T; Noiri E
Crit Care Med; 2011 Nov; 39(11):2464-9. PubMed ID: 21705884
[TBL] [Abstract][Full Text] [Related]
5. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.
Dusse F; Edayadiyil-Dudásova M; Thielmann M; Wendt D; Kahlert P; Demircioglu E; Jakob H; Schaefer ST; Pilarczyk K
BMC Anesthesiol; 2016 Sep; 16():76. PubMed ID: 27609347
[TBL] [Abstract][Full Text] [Related]
6. Molecular markers for ischemia, do we have something better then creatinine and glomerular filtration rate?
Sprenkle P; Russo P
Arch Esp Urol; 2013; 66(1):99-114. PubMed ID: 23406805
[TBL] [Abstract][Full Text] [Related]
7. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
Waring WS; Moonie A
Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of renal function, which and when?
Wasung ME; Chawla LS; Madero M
Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in acute kidney injury - pathophysiological basis and clinical performance.
Schrezenmeier EV; Barasch J; Budde K; Westhoff T; Schmidt-Ott KM
Acta Physiol (Oxf); 2017 Mar; 219(3):554-572. PubMed ID: 27474473
[TBL] [Abstract][Full Text] [Related]
10. Bench to bedside: the next steps for biomarkers in acute kidney injury.
Pickering JW; Endre ZH
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F717-F721. PubMed ID: 27465990
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of Drug-Induced Kidney Toxicity.
Griffin BR; Faubel S; Edelstein CL
Ther Drug Monit; 2019 Apr; 41(2):213-226. PubMed ID: 30883514
[TBL] [Abstract][Full Text] [Related]
13. Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine.
Buelow MW; Dall A; Regner K; Weinberg C; Bartz PJ; Sowinski J; Rudd N; Katzmark L; Tweddell JS; Earing MG
Congenit Heart Dis; 2012; 7(5):441-7. PubMed ID: 22537138
[TBL] [Abstract][Full Text] [Related]
14. Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.
Zappitelli M; Greenberg JH; Coca SG; Krawczeski CD; Li S; Thiessen-Philbrook HR; Bennett MR; Devarajan P; Parikh CR;
JAMA Pediatr; 2015 Jun; 169(6):583-91. PubMed ID: 25844892
[TBL] [Abstract][Full Text] [Related]
15. Innovative Use of Novel Biomarkers to Improve the Safety of Renally Eliminated and Nephrotoxic Medications.
Barreto EF; Rule AD; Voils SA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):794-803. PubMed ID: 29883532
[TBL] [Abstract][Full Text] [Related]
16. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
[TBL] [Abstract][Full Text] [Related]
17. Emergence of biomarkers in nephropharmacology.
Khan E; Batuman V; Lertora JJ
Biomark Med; 2010 Dec; 4(6):805-14. PubMed ID: 21133700
[TBL] [Abstract][Full Text] [Related]
18. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature.
Vanmassenhove J; Vanholder R; Nagler E; Van Biesen W
Nephrol Dial Transplant; 2013 Feb; 28(2):254-73. PubMed ID: 23115326
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption.
Kashani K; Cheungpasitporn W; Ronco C
Clin Chem Lab Med; 2017 Jul; 55(8):1074-1089. PubMed ID: 28076311
[TBL] [Abstract][Full Text] [Related]
20. Interventions, Barriers, and Proposed Solutions Associated With the Implementation of a Protocol That Uses Clinical Decision Support and a Stress Biomarker Test to Identify ICU Patients at High-Risk for Drug Associated Acute Kidney Injury.
Williams VL; Smithburger PL; Imhoff AN; Groetzinger LM; Culley CM; Burke CX; Murugan R; Lamberty PE; Mahmud M; Benedict NJ; Kellum JA; Kane-Gill SL
Ann Pharmacother; 2023 Apr; 57(4):408-415. PubMed ID: 35962583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
